drugset / Trial / NCT00447811

Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

NCT00447811

Phase 1 Completed Bausch Health Americas, Inc.
RandomizedCrossoverDouble-blindDiagnostic

Summary

This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MOA-728 in subjects on stable methadone maintenance.

Timeline

Start
2007-03
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified Oral

Indications

No indication recorded.